Drug Profile
Doxorubicin - Nippon Kayaku
Alternative Names: Doxorubicin "NK"; Doxorubicin micelle; Micelle doxorubicin hydrochloride; Micelle-encapsulated doxorubicin; NK 911Latest Information Update: 14 Jan 2022
Price :
$50
*
At a glance
- Originator Tokyo Womens Medical University
- Developer Nippon Kayaku
- Class Anthracyclines; Antineoplastics; Cytostatic antibiotics; Doxorubicins; Small molecules
- Mechanism of Action DNA intercalators; Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Lymphoma
Most Recent Events
- 06 Feb 2019 Chemical structure information added
- 07 Jul 2003 Phase-I clinical trials in Cancer in Japan (Parenteral)